Quinoline Yellow WS

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name

Quinoline Yellow WS

Accession Number

DB14231

Description

Not Available

Type

Small Molecule

Groups

Experimental

Purchasing individual compounds or compound libraries for your research?

Learn More

Synonyms

C.I. Food Yellow 13
D & C Yellow No. 10
D and C Yellow No. 10
D&C Yellow No. 10
Food Yellow 13
Japan Yellow 203

Pharmacology

Indication: Not Available
Contraindications & Blackbox Warnings: Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics: Not Available
Mechanism of action: Not Available
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half-life: Not Available
Clearance: Not Available
Adverse Effects: Learn about our commercial Adverse Effects data.
Learn More
Toxicity: Not Available
Affected organisms: Not Available
Pathways: Not Available
Pharmacogenomic Effects/ADRs: Not Available

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Drug	Interaction
Unlock Additional Data
Acebutolol	Quinoline Yellow WS may decrease the antihypertensive activities of Acebutolol.
Aceclofenac	The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aceclofenac is combined with Quinoline Yellow WS.
Acemetacin	The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Quinoline Yellow WS.
Acetylsalicylic acid	The therapeutic efficacy of Quinoline Yellow WS can be decreased when used in combination with Acetylsalicylic acid.
Agrostis gigantea pollen	The risk or severity of adverse effects can be increased when Quinoline Yellow WS is combined with Agrostis gigantea pollen.
Agrostis stolonifera pollen	The risk or severity of adverse effects can be increased when Quinoline Yellow WS is combined with Agrostis stolonifera pollen.
Alclofenac	The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Alclofenac is combined with Quinoline Yellow WS.
Alfentanil	The risk or severity of hypertension can be increased when Alfentanil is combined with Quinoline Yellow WS.
Aliskiren	The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Quinoline Yellow WS.
Allopurinol	The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Quinoline Yellow WS.